Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (BRAVECTO® TriUNO) in dogs for the treatment and prevention of angiostrongylosis

Saved in:
Bibliographic Details
Published in:Parasites & Vectors
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871837825067909121
collection WordPress RSS
FRELIP Feed Integration
container_title Parasites & Vectors
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:106436
institution FRELIP
journal_source_facet Parasites & Vectors
last_indexed 2026-07-27T03:40:58.044Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (BRAVECTO® TriUNO) in dogs for the treatment and prevention of angiostrongylosis
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title Efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (BRAVECTO® TriUNO) in dogs for the treatment and prevention of angiostrongylosis
title_alt Eficacia de una administración oral única de una formulación de fluralaner, moxidectina y pirantel (BRAVECTO® TriUNO) en perros para el tratamiento y prevención de la angiostrongilosis
Efficacité d'une administration orale unique d'une formulation de fluralaner, moxidectine et pyrantel (BRAVECTO® TriUNO) chez le chien pour le traitement et la prévention de l'angiostrongylose
Eficácia de uma Única Administração Oral de uma Formulação de Fluralaner, Moxidectina e Pirantel (BRAVECTO® TriUNO) em Cães para o Tratamento e Prevenção da Angiostrongilose
title_auth Efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (BRAVECTO® TriUNO) in dogs for the treatment and prevention of angiostrongylosis
title_es_txt Eficacia de una administración oral única de una formulación de fluralaner, moxidectina y pirantel (BRAVECTO® TriUNO) en perros para el tratamiento y prevención de la angiostrongilosis
title_fr_txt Efficacité d'une administration orale unique d'une formulation de fluralaner, moxidectine et pyrantel (BRAVECTO® TriUNO) chez le chien pour le traitement et la prévention de l'angiostrongylose
title_full Efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (BRAVECTO® TriUNO) in dogs for the treatment and prevention of angiostrongylosis
title_fullStr Efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (BRAVECTO® TriUNO) in dogs for the treatment and prevention of angiostrongylosis
title_full_unstemmed Efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (BRAVECTO® TriUNO) in dogs for the treatment and prevention of angiostrongylosis
title_pt_txt Eficácia de uma Única Administração Oral de uma Formulação de Fluralaner, Moxidectina e Pirantel (BRAVECTO® TriUNO) em Cães para o Tratamento e Prevenção da Angiostrongilose
title_short Efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (BRAVECTO® TriUNO) in dogs for the treatment and prevention of angiostrongylosis
title_sort efficacy of a single oral administration of a formulation of fluralaner, moxidectin and pyrantel (bravecto® triuno) in dogs for the treatment and prevention of angiostrongylosis
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://link.springer.com/article/10.1186/s13071-026-07529-4